CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Predictive Oncology Inc. - POAI CFD

    2.89
    2.69%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.13
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 2.97
    Open* 2.98
    1-Year Change* 645%
    Day's Range* 2.89 - 3.01
    52 wk Range 2.47-13.88
    Average Volume (10 days) 16.04K
    Average Volume (3 months) 441.79K
    Market Cap 12.23M
    P/E Ratio -100.00K
    Shares Outstanding 4.06M
    Revenue 1.81M
    EPS -4.64
    Dividend (Yield %) N/A
    Beta 1.54
    Next Earnings Date Mar 19, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 2.89 -0.09 -3.02% 2.98 3.01 2.89
    Dec 7, 2023 2.97 -0.12 -3.88% 3.09 3.12 2.97
    Dec 6, 2023 3.19 0.12 3.91% 3.07 3.23 3.07
    Dec 5, 2023 3.15 0.01 0.32% 3.14 3.22 3.10
    Dec 4, 2023 3.20 0.03 0.95% 3.17 3.24 3.12
    Dec 1, 2023 3.16 -0.01 -0.32% 3.17 3.22 3.09
    Nov 30, 2023 3.18 0.11 3.58% 3.07 3.28 3.07
    Nov 29, 2023 3.07 0.07 2.33% 3.00 3.12 3.00
    Nov 28, 2023 2.98 0.08 2.76% 2.90 3.02 2.88
    Nov 27, 2023 2.89 0.02 0.70% 2.87 3.00 2.82
    Nov 24, 2023 2.92 0.13 4.66% 2.79 2.99 2.79
    Nov 22, 2023 2.88 0.04 1.41% 2.84 2.92 2.78
    Nov 21, 2023 2.98 0.06 2.05% 2.92 2.99 2.92
    Nov 20, 2023 2.95 0.17 6.12% 2.78 2.95 2.78
    Nov 17, 2023 2.84 -0.14 -4.70% 2.98 2.98 2.83
    Nov 16, 2023 2.91 -0.17 -5.52% 3.08 3.08 2.88
    Nov 15, 2023 3.08 -0.02 -0.65% 3.10 3.12 3.08
    Nov 14, 2023 3.08 0.00 0.00% 3.08 3.18 3.05
    Nov 13, 2023 3.08 -0.09 -2.84% 3.17 3.17 3.06
    Nov 10, 2023 3.16 0.02 0.64% 3.14 3.24 3.14

    Predictive Oncology Inc. Events

    Time (UTC) Country Event
    Tuesday, March 19, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 Predictive Oncology Inc Earnings Release
    Q4 2023 Predictive Oncology Inc Earnings Release

    Forecast

    -

    Previous

    -
    Thursday, April 18, 2024

    Time (UTC)

    20:00

    Country

    US

    Event

    Predictive Oncology Inc Annual Shareholders Meeting
    Predictive Oncology Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 1.50546 1.42068 1.25227 1.41157 1.41166
    Revenue 1.50546 1.42068 1.25227 1.41157 1.41166
    Cost of Revenue, Total 0.50511 0.48702 0.44719 0.53181 0.41576
    Gross Profit 1.00035 0.93366 0.80508 0.87976 0.9959
    Total Operating Expense 27.5391 21.8493 28.609 24.6374 9.27303
    Selling/General/Admin. Expenses, Total 12.4696 11.7067 10.9369 11.6941 6.99615
    Interest Expense (Income) - Net Operating
    Other Operating Expenses, Total 3.79843 2.69857 2.35171 2.96013 1.86112
    Operating Income -26.0336 -20.4286 -27.3567 -23.2258 -7.86137
    Net Income Before Taxes -25.7376 -20.3188 -25.8844 -19.3908 -10.0865
    Net Income After Taxes -25.7376 -19.6572 -25.8844 -19.3908 -10.0865
    Net Income Before Extra. Items -25.7376 -19.6572 -25.8844 -19.3908 -10.0865
    Net Income -25.7376 -19.6572 -25.8844 -19.3908 -10.0865
    Income Available to Common Excl. Extra. Items -25.7376 -19.6572 -26.4387 -19.6807 -10.0865
    Income Available to Common Incl. Extra. Items -25.7376 -19.6572 -26.4387 -19.6807 -10.0865
    Diluted Net Income -25.7376 -19.6572 -26.4387 -19.6807 -10.0865
    Diluted Weighted Average Shares 3.6499 2.7438 0.59751 0.14351 0.06408
    Diluted EPS Excluding Extraordinary Items -7.0516 -7.16421 -44.2483 -137.141 -157.401
    Diluted Normalized EPS -4.10195 -5.5161 -19.3562 -71.2816 -157.401
    Interest Income (Expense), Net Non-Operating 0.11565 0.1649 3.05591 5.72462 -2.29358
    Other, Net 0.18037 -0.0551 -1.58359 -1.88957 0.06848
    Total Adjustments to Net Income 0 -0.55429 -0.28994
    Unusual Expense (Income) 10.7659 6.95707 14.8732 9.45132
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0.49011 0.2399 0.36347 0.45583 0.37159
    Revenue 0.49011 0.2399 0.36347 0.45583 0.37159
    Cost of Revenue, Total 0.15976 0.12014 0.15344 0.10815 0.13408
    Gross Profit 0.33035 0.11976 0.21003 0.34768 0.23751
    Total Operating Expense 4.44934 3.70488 8.3269 4.58658 10.897
    Selling/General/Admin. Expenses, Total 3.1266 2.69956 3.49751 3.6213 2.62272
    Other Operating Expenses, Total 0.99304 0.87852 1.14111 0.85713 0.90911
    Operating Income -3.95923 -3.46498 -7.96343 -4.13075 -10.5254
    Interest Income (Expense), Net Non-Operating 0.00731 0.00095 0.00827 0.01022 0.09525
    Other, Net 0.02855 0.04223 0.03905 0.06105 0.03883
    Net Income Before Taxes -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
    Net Income After Taxes -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
    Net Income Before Extra. Items -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
    Net Income -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
    Income Available to Common Excl. Extra. Items -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
    Income Available to Common Incl. Extra. Items -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
    Diluted Net Income -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
    Diluted Weighted Average Shares 3.99651 3.9681 3.93693 3.91919 3.44483
    Diluted EPS Excluding Extraordinary Items -0.9817 -0.86233 -2.01073 -1.0358 -3.0165
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.94094 -0.86233 -1.11286 -1.0358 -0.91738
    Unusual Expense (Income) 0.16291 3.53484 0 7.23109
    Total Adjustments to Net Income
    Depreciation / Amortization 0.00704 0.00667
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 23.36 29.4583 1.51424 0.79826 1.45153
    Cash and Short Term Investments 22.0715 28.2026 0.67833 0.15083 0.16215
    Cash 22.0715 28.2026 0.67833 0.15083 0.16215
    Short Term Investments 0
    Total Receivables, Net 0.3312 0.3542 0.25688 0.29706 0.72988
    Accounts Receivable - Trade, Net 0.3312 0.3542 0.25688 0.29706 0.2326
    Total Inventory 0.43049 0.38768 0.28954 0.19016 0.24107
    Prepaid Expenses 0.5268 0.51378 0.28949 0.16022 0.31843
    Total Assets 25.7346 43.7713 13.0604 22.3755 3.709
    Property/Plant/Equipment, Total - Net 2.04515 3.32603 5.21805 2.23754 0.18045
    Intangibles, Net 0.25387 3.96212 3.3981 3.64941 0.9645
    Total Current Liabilities 3.88267 3.24051 9.33692 10.8739 3.65553
    Accounts Payable 0.94345 1.02177 1.37207 3.15564 0.44569
    Accrued Expenses 2.32331 1.9023 3.18552 2.83111 1.27911
    Notes Payable/Short Term Debt 0 0 0 4.7958 1.63491
    Other Current Liabilities, Total 0.61591 0.31643 0.34741 0.09137 0.29581
    Total Liabilities 3.96875 3.50559 10.4178 11.1442 3.65553
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 0.08608 0.26508 1.08083 0.27026
    Total Equity 21.7659 40.2657 2.64268 11.2313 0.05347
    Preferred Stock - Non Redeemable, Net 0.00079 0.00079 0.00079 0.0358 0.00079
    Common Stock 0.78763 0.65615 0.19805 0.04057 0.14092
    Additional Paid-In Capital 174.755 167.649 110.827 93.6537 63.0197
    Retained Earnings (Accumulated Deficit) -153.778 -128.04 -108.383 -82.4987 -63.1079
    Other Equity, Total
    Total Liabilities & Shareholders’ Equity 25.7346 43.7713 13.0604 22.3755 3.709
    Total Common Shares Outstanding 3.93814 3.28073 0.99024 0.20283 0.07046
    Total Preferred Shares Outstanding 0.07925 0.07925 0.07925 3.5795 0.07925
    Note Receivable - Long Term 0 1.11252
    Property/Plant/Equipment, Total - Gross 4.92275 5.39436 6.5499 3.00912
    Accumulated Depreciation, Total -2.8776 -2.06834 -1.33185 -0.77157
    Goodwill, Net 0 6.85779 2.81379 15.6903
    Other Long Term Assets, Total 0.07562 0.16707 0.11626
    Current Port. of LT Debt/Capital Leases 0 4.43193
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 13.5205 15.9695 19.7802 23.36 26.8573
    Cash and Short Term Investments 11.915 14.7638 18.5971 22.0715 25.3937
    Cash 11.915 14.7638 18.5971 22.0715 25.3937
    Total Receivables, Net 0.54476 0.43085 0.28276 0.3312 0.32471
    Accounts Receivable - Trade, Net 0.54476 0.43085 0.28276 0.3312 0.32471
    Total Inventory 0.43999 0.3937 0.38029 0.43049 0.49372
    Prepaid Expenses 0.62069 0.38123 0.52001 0.5268 0.64515
    Total Assets 18.1669 20.967 25.0616 25.7346 33.1662
    Property/Plant/Equipment, Total - Net 4.26297 4.5572 4.83434 2.04515 2.53167
    Property/Plant/Equipment, Total - Gross 7.69956 7.83767 7.9417 4.92275 5.24453
    Accumulated Depreciation, Total -3.43659 -3.28047 -3.10737 -2.8776 -2.71287
    Goodwill, Net 0 0
    Intangibles, Net 0.25932 0.26618 0.27297 0.25387 3.7016
    Other Long Term Assets, Total 0.1241 0.1741 0.1741 0.07562 0.07562
    Total Current Liabilities 4.17189 3.76334 3.91035 3.88267 3.46808
    Accounts Payable 1.16823 1.01348 1.42448 0.94345 0.91727
    Accrued Expenses 2.36638 2.11639 1.83375 2.32331 2.03334
    Notes Payable/Short Term Debt 0.26022 0 0 0 0
    Other Current Liabilities, Total 0.37707 0.63347 0.65212 0.61591 0.51746
    Total Liabilities 6.51551 6.26195 6.50719 3.96875 3.57333
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 2.34362 2.49861 2.59685 0.08608 0.10525
    Total Equity 11.6514 14.7051 18.5544 21.7659 29.5929
    Preferred Stock - Non Redeemable, Net 0.00079 0.00079 0.00159 0.00079 0.00079
    Common Stock 0.04033 0.04006 0.0397 0.78763 0.78407
    Additional Paid-In Capital 175.897 175.787 175.713 174.755 174.67
    Retained Earnings (Accumulated Deficit) -164.287 -161.123 -157.2 -153.778 -145.862
    Total Liabilities & Shareholders’ Equity 18.1669 20.967 25.0616 25.7346 33.1662
    Total Common Shares Outstanding 4.03329 4.0063 3.96999 3.93814 3.92037
    Total Preferred Shares Outstanding 0.07925 0.07925 0.07925 0.07925 0.07925
    Current Port. of LT Debt/Capital Leases
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -25.7376 -19.6572 -25.8844 -19.3908 -10.0865
    Cash From Operating Activities -12.3708 -12.2089 -12.2577 -8.73245 -5.28796
    Cash From Operating Activities 1.31308 1.3403 1.02485 0.70488 0.14763
    Non-Cash Items 11.1871 7.30233 13.8147 8.07998 3.76659
    Cash Interest Paid 0.00382 0.69051 0.14583
    Changes in Working Capital 0.86669 -1.19438 -1.21288 1.87345 0.8843
    Cash From Investing Activities -0.4757 -10.6075 -0.16746 -0.59909 -1.11065
    Capital Expenditures -0.4757 -0.96232 -0.36078 -0.02661 -0.232
    Other Investing Cash Flow Items, Total 0 -9.64521 0.19332 -0.57248 -0.87865
    Cash From Financing Activities 6.71541 50.3408 12.9527 9.32022 5.79457
    Issuance (Retirement) of Stock, Net 6.71541 55.7015 11.8851 7.98702 3.60957
    Issuance (Retirement) of Debt, Net 0 1.28948 1.53549 2.185
    Net Change in Cash -6.13109 27.5243 0.5275 -0.01132 -0.60404
    Financing Cash Flow Items 0 -5.36071 -0.22191 -0.20229
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -3.4218 -25.7376 -17.8215 -13.762 -3.37072
    Cash From Operating Activities -3.42776 -12.3708 -9.13581 -6.42781 -3.0937
    Cash From Operating Activities 0.23785 1.31308 0.98038 0.64944 0.3236
    Non-Cash Items 0.02035 11.1871 7.5351 7.42432 0.19793
    Changes in Working Capital -0.26416 0.86669 0.17023 -0.73953 -0.24452
    Cash From Investing Activities -0.04664 -0.4757 -0.4121 -0.26842 -0.08024
    Capital Expenditures -0.04664 -0.4757 -0.4121 -0.26842 -0.08024
    Cash From Financing Activities 0 6.71541 6.73903 6.74306 0.08689
    Financing Cash Flow Items 0 0 0 0
    Issuance (Retirement) of Stock, Net 0 6.71541 6.73903 6.74306 0.08689
    Net Change in Cash -3.4744 -6.13109 -2.80888 0.04684 -3.08705
    Cash Interest Paid 0.00382 0.00375 0.00144
    Issuance (Retirement) of Debt, Net
    Other Investing Cash Flow Items, Total 0

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Predictive Oncology Inc. Company profile

    Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Helomics, Soluble, and Skyline. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers'' exposure to infectious fluids collected during surgical and other patient procedures, as well as proprietary cleaning fluid and filters to users of its systems. The company also provides contract research organization (CRO) and AI-driven predictive models of tumor drug response to improve clinical outcomes to assist pharmaceutical, diagnostic, and biotech industries; and soluble and stable formulations for proteins, including vaccines, antibodies, and other protein therapeutics, as well as develops tumor models for precision cancer therapy and drug development. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence (AI) applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
    Industry: Medical Equipment, Supplies & Distribution (NEC)

    2915 Commers Dr Ste 900
    EAGAN
    MINNESOTA 55121-2363
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    XRP/USD

    0.68 Price
    +0.300% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Gold

    2,004.85 Price
    -1.180% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    BTC/USD

    44,078.85 Price
    -1.220% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Oil - Crude

    71.41 Price
    +2.320% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading